| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |